Injections for Knee Osteoarthritis: Corticosteroids, Viscosupplementation, Platelet-Rich Plasma, and Autologous Stem Cells

David M Levy; Kyle A Petersen; Margie Scalley Vaught; David R Christian; Brian J Cole

doi:10.1016/j.arthro.2018.02.022

Injections for Knee Osteoarthritis: Corticosteroids, Viscosupplementation, Platelet-Rich Plasma, and Autologous Stem Cells

Arthroscopy. 2018 May;34(5):1730-1743. doi: 10.1016/j.arthro.2018.02.022. Epub 2018 Apr 12.

Authors

David M Levy¹, Kyle A Petersen¹, Margie Scalley Vaught², David R Christian¹, Brian J Cole³

Affiliations

¹ Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, U.S.A.
² Auditing, Coding, Documentation and Compliance Consulting, Chehalis, Washington, U.S.A.
³ Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, U.S.A.. Electronic address: bcole@rushortho.com.

PMID: 29656808
DOI: 10.1016/j.arthro.2018.02.022

Abstract

This article reviews the benefits of corticosteroid, viscosupplementation, platelet-rich plasma, and autologous mesenchymal stem cell injections for the treatment of patients with knee osteoarthritis. Integrating injections into both clinical and surgical practices is complicated given existing health insurance reimbursement policies. This review describes the outcomes associated with these interventions and appropriate methods of navigating the existing reimbursement pathways to help providers implement these treatments into their practices.

Publication types

Review

MeSH terms

Adrenal Cortex Hormones / administration & dosage*
Humans
Injections, Intra-Articular
Osteoarthritis, Knee / therapy*
Platelet-Rich Plasma*
Stem Cell Transplantation / methods*
Transplantation, Autologous
Viscosupplementation / methods*
Viscosupplements / administration & dosage*

Substances

Adrenal Cortex Hormones
Viscosupplements